GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » Quick Ratio

Arch Biopartners (TSXV:ARCH) Quick Ratio : 0.11 (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Arch Biopartners's quick ratio for the quarter that ended in Dec. 2023 was 0.11.

Arch Biopartners has a quick ratio of 0.11. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Arch Biopartners's Quick Ratio or its related term are showing as below:

TSXV:ARCH' s Quick Ratio Range Over the Past 10 Years
Min: 0.11   Med: 0.75   Max: 9.14
Current: 0.11

During the past 13 years, Arch Biopartners's highest Quick Ratio was 9.14. The lowest was 0.11. And the median was 0.75.

TSXV:ARCH's Quick Ratio is ranked worse than
96.27% of 1553 companies
in the Biotechnology industry
Industry Median: 3.49 vs TSXV:ARCH: 0.11

Arch Biopartners Quick Ratio Historical Data

The historical data trend for Arch Biopartners's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Quick Ratio Chart

Arch Biopartners Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.42 0.61 0.84 0.22 0.20

Arch Biopartners Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.54 0.33 0.20 0.11

Competitive Comparison of Arch Biopartners's Quick Ratio

For the Biotechnology subindustry, Arch Biopartners's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arch Biopartners's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's Quick Ratio falls into.



Arch Biopartners Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Arch Biopartners's Quick Ratio for the fiscal year that ended in Sep. 2023 is calculated as

Quick Ratio (A: Sep. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1.171-0)/5.977
=0.20

Arch Biopartners's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.636-0)/5.85
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arch Biopartners  (TSXV:ARCH) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Arch Biopartners Quick Ratio Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Arch Biopartners (TSXV:ARCH) Business Description

Traded in Other Exchanges
N/A
Address
545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.

Arch Biopartners (TSXV:ARCH) Headlines

From GuruFocus

Arch Resources Inc (ARCH) Reports Q3 2023 Earnings

By GuruFocus Research 10-26-2023

LUMINUS MANAGEMENT LLC Goes on Buying Spree in 4th Quarter

By GuruFocus Research GuruFocus Editor 02-18-2023

Arch Resources Publishes 2022 Sustainability Report

By PRNewswire PRNewswire 06-30-2022

2 Undervalued Coal Miners to Consider

By Steve Gray Booyens 06-27-2022

LUMINUS MANAGEMENT LLC Buys 3, Sells 2 in 3rd Quarter

By GuruFocus Research GuruFocus Editor 11-15-2022